Ajay Madan, Ph.D., DABT

Neurocrine Biosciences


Dr. Madan is the Senior Director of Preclinical Development at Neurocrine Biosciences where he has participated in the discovery and development of several drugs in the CNS and endocrine areas. He received his Ph.D. from the University of Kansas, and is a board certified toxicologist. Before joining Neurocrine, he was the Chief Scientific Officer of XenoTech LLC, where he worked with several pharmaceutical companies in characterization and risk assessment of metabolism liabilities of new chemical entities. He has extensive  experience in the use of in vitro systems for predicting drug-drug interactions, human pharmacokinetics and toxicology in the drug discovery stage. He is the author of 45 publications in these topics and an instructor in preclinical drug discovery and development at the University of California San Diego.